AZEMIDITE
LIVE

Serial Number

79368347

Owner

Azemidite Biopharm Co., Ltd.

Attorney

Zhi Dong

Filing Date

Feb 23, 2023

Add to watchlist:

No watchlists yet
View on USPTO

AZEMIDITE Trademark

Serial Number: 79368347 • Registration: 7546656

AZEMIDITE is a trademark filed by Azemidite Biopharm Co., Ltd. on February 23, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Azemidite Biopharm Co., Ltd. (2 trademarks)

3 Xinzhang Road, West District,

Entity Type: 99

Trademark Details

Filing Date

February 23, 2023

Registration Date

October 29, 2024

Published for Opposition

August 13, 2024

Goods & Services

Medicines for humans for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; pharmaceutical preparations for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; chemico-pharmaceutical preparations for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; vaccines; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; biological preparations for medical purposes for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, genetic disordersand rare ocular, respiratory, gastrointestinal, cerebral diseases; chemical preparations for pharmaceutical purposes for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; chemical preparations for medical purposes for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; diagnostic biomarker reagents for medical purposes; crude drugs being pharmaceutical preparations for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; biochemical medicines, namely, antidepressants, appetite suppressants, cardiovascular drugs, antitumor drugs and hypoglycemic drugs; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes; dietetic substances adapted for medical use, namely, dietary supplements and dietetic foods adapted for medical use; depuratives for the body; veterinary preparations for the treatment of gastrointestinal diseases, cardiovascular diseases, metabolic diseases, and liver diseases; pesticides; disinfectant wipes; dressings, medical; composite materials for dental purposes; diapers for pets

Glucosides being chemicals for industrial purposes; carbonic hydrates; polymer resins, unprocessed; artificial resins, unprocessed; chemical preparations in the nature of ion-exchange resins; enzymes for industrial purposes; enzymes for the food industry; biochemical catalysts; catalysts for chemical processes; industrial chemicals; chemical preparations for scientific purposes, other than for medical or veterinary use; chemical reagents, other than for medical or veterinary purposes; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; cryogenic preparations in solid, liquid or gas state for use in chilling and freezing; diagnostic preparations, other than for medical or veterinary purposes

Custom assembling of materials for others, namely, custom manufacture of industrial chemicals, pharmaceuticals; providing information relating to material treatment; metal treating; rental of machines and apparatus for processing food; typesetting; recycling of chemicals; processing of chemical reagents for use in manufacture; rental of chemical processing machines; custom manufacturing of make-up

Scientific laboratory services; scientific research; technical writing; technological research in the field of pharmaceutical manufacturing processes and pharmaceutical studies; quality control for others; chemistry services, namely, chemistry consultation, research in the field of chemistry; chemical research and analysis; development and testing of chemical production methods; biochemical research and development; chemistry consultation

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 19, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 31, 2025 FICS
FINAL DISPOSITION PROCESSED
Mar 31, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 29, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 29, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 29, 2024 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 12, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 25, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 25, 2024 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 13, 2024 NPUB
PUBLISHED FOR OPPOSITION
Aug 13, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 24, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 2, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 2, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 2, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 2, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 2, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 28, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 28, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 28, 2024 TROA
REFUSAL PROCESSED BY IB
Dec 26, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 1, 2023 RFCS
REFUSAL PROCESSED BY MPU
Nov 30, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 30, 2023 RFCR
NON-FINAL ACTION WRITTEN
Nov 29, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 24, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
May 2, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 28, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 27, 2023 REPR